HFS
BIO icon

Hughes Financial Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Hughes Financial Services’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.82K Buy
13
+2
+18% +$567 ﹤0.01% 593
2026
Q1 		$3.07K Buy
11
+1
+10% +$288 ﹤0.01% 508
2025
Q4 		$3.03K Buy
+10
New +$3.12K ﹤0.01% 467

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Hughes Financial Services's BIO Position: Q2 2026 in Review

Hughes Financial Services increased its Bio-Rad Laboratories Class A (BIO) stake by 18% in Q2 2026, buying an estimated $567 and bringing the position to 13 shares worth $3.82K. The position accounts for ﹤0.01% of the portfolio, ranked #593.

Hughes Financial Services first reported a position in BIO in Q4 2025 and has held it in 3 quarters since. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Hughes Financial Services held 13 shares of Bio-Rad Laboratories Class A worth $3.82K as of Q2 2026.
  • Hughes Financial Services bought 2 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $567.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #593 holding.
  • Hughes Financial Services first reported a position in Bio-Rad Laboratories Class A in Q4 2025 and has held it in 3 quarters since.
  • 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.